Detailed analysis of sputum and systemic inflammation in asthma phenotypes: Are paucigranulocytic asthmatics really non-inflammatory?

BMC Pulmonary Medicine

Volumn 16, Issue 1, 2016, Pages

  Demarche, Sophie ^a,b   Schleich, Florence ^a,b   Henket, Monique ^a,b   Paulus, Virginie ^a,b   Van Hees, Thierry ^b   Louis, Renaud ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Asthma; Blood leukocyte count; CRP; Fibrinogen; Healthy subjects; Phenotypes; Sputum cytology

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ARTICLE; ASTHMA; ATOPY; CELL VIABILITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EOSINOPHIL; EPITHELIUM CELL; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATION; LYMPHOCYTE COUNT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PAUCIGRANULOCYTIC ASTHMA; PHENOTYPE; RETROSPECTIVE STUDY; SMOKING; SPUTUM ANALYSIS; SYSTEMIC DISEASE; AGED; CASE CONTROL STUDY; CYTOLOGY; GRANULOCYTE; IMMUNOLOGY; LEUKOCYTE COUNT; MIDDLE AGED; NEUTROPHIL; SPUTUM;

ADULT; AGED; ASTHMA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EOSINOPHILS; FEMALE; FIBRINOGEN; GRANULOCYTES; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; PHENOTYPE; RETROSPECTIVE STUDIES; SPUTUM;

EID: 85007507905     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-016-0208-2     Document Type: Article

References (33)

1. Pavord ID, Pizzichini MM, Pizzichini E, Hargreave FE. The use of induced sputum to investigate airway inflammation. Thorax. 1997;52:498-501.
2. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirol Carlton Vic. 2006;11:54-61.
3. Schleich FN, Manise M, Sele J, Henket M, Seidel L, Louis R. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm Med. 2013;13:11.
4. In't Veen JC, de Gouw HW, Smits HH, Sont JK, Hiemstra PS, Sterk PJ, et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J. 1996;9:2441-7.
5. Bacci E, Cianchetti S, Carnevali S, Bartoli ML, Dente FL, Di Franco A, et al. Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediators Inflamm. 2002;11:293-8.
6. Vlachos-Mayer H, Leigh R, Sharon RF, Hussack P, Hargreave FE. Success and safety of sputum induction in the clinical setting. Eur Respir J. 2000;16:997-1000.
7. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002;57:875-9.
8. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol. 2007;119:1043-52. quiz 1053-4.
9. Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP, et al. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol. 2010;125:1028-36. e13.
10. Porsbjerg C, Lund TK, Pedersen L, Backer V. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO. J Asthma OffJ Assoc Care Asthma. 2009;46:606-12.
11. Zhang X-Y, Simpson JL, Powell H, Yang IA, Upham JW, Reynolds PN, et al. Full blood count parameters for the detection of asthma inflammatory phenotypes. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2014;44:1137-45.
12. Delvaux M, Henket M, Lau L, Kange P, Bartsch P, Djukanovic R, et al. Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax. 2004;59:111-5.
13. Gershman NH, Wong HH, Liu JT, Mahlmeister MJ, Fahy JV. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur Respir J. 1996;9:2448-53.
14. Louis R, Godinas L, Schleich F. Induced Sputum-Towards Normal Values. Non Invasive Assessment of airways inflammation in asthma and COPD. Athens: Paschalidis Medical Publications; 2011. p. 113-23.
15. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57:643-8.
16. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol Baltim Md 1950. 1996;156:4422-8.
17. Kamath AV, Pavord ID, Ruparelia PR, Chilvers ER. Is the neutrophil the key effector cell in severe asthma? Thorax. 2005;60:529-30.
18. Louis R, Schleich F, Barnes PJ. Corticosteroids: still at the frontline in asthma treatment? Clin Chest Med. 2012;33:531-41.
19. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax. 2010;65:384-90.
20. Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy. 2011;66:989-98.
21. Bradley BL, Azzawi M, Jacobson M, AssoufiB, Collins JV, Irani AM, et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol. 1991;88:661-74.
22. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol. 1991;88:935-42.
23. Simpson JL, Gibson PG, Yang IA, Upham J, James A, Reynolds PN, et al. Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2013;43:29-35.
24. Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol. 2011;128:451-62. quiz 463-4.
25. Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R, et al. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res. 2011;12:146.
26. Gibson PG, Manning PJ, O'Byrne PM, Girgis-Gabardo A, Dolovich J, Denburg JA, et al. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors. Am Rev Respir Dis. 1991;143:331-5.
27. Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest. 2012;142:86-93.
28. Berry M, Morgan A, Shaw DE, Parker D, Green R, Brightling C, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax. 2007;62:1043-9.
29. Jatakanon A, Kharitonov S, Lim S, Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax. 1999;54:108-14.
30. Lewis SA, Pavord ID, Stringer JR, Knox AJ, Weiss ST, Britton JR. The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults. Chest. 2001;119:105-14.
31. Boulet L-P, Lemière C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest. 2006;129:661-8.
32. Telenga ED, Kerstjens HAM, Ten Hacken NHT, Postma DS, van den Berge M. Inflammation and corticosteroid responsiveness in ex-, current-and neversmoking asthmatics. BMC Pulm Med. 2013;13:58.
33. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med. 2012;185:612-9.